Clinical Trial Update: ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis- [Phase 2]

View source ↗

Summary

This document reports the completion status of a Phase 2 double-blind study evaluating ASP1517 for the treatment of anemia in patients with chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• ASP1517

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Anemia in Chronic Kidney Disease Patients Not on Dialysis | Phase 2 | Status: COMPLETED